Publications
- Role of linezolid in the treatment of resistant gram-positive infections2006 | Third Faculty of Medicine, First Faculty of Medicine
- The role of linezolide in the treatment of resistant gram-positive infections2005 | Third Faculty of Medicine, Central Library of Charles University
- BIOREP - Biologic/Targeted Therapy Registry: 2022 Summary Report2023 | Third Faculty of Medicine, First Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen
- Dupilumab for the treatment of atopic dermatitis: Real-world data from the Czech Republic BIOREP registry2022 | Third Faculty of Medicine, First Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen
- Efficacy, safety, and drug survival of patients with psoriasis treated with IL-17 inhibitors - brodalumab, ixekizumab, and secukinumab: real-world data from the Czech Republic BIOREP registry2022 | Third Faculty of Medicine, First Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen
- Efficacy of switches within the class of IL-17 inhibitors: An analysis of data from the Czech nationwide registry of psoriatic patients receiving biological/targeted therapy (BIOREP)2022 | Third Faculty of Medicine, First Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen
- Registry of Biological/Targeted Therapy BIOREP - Summary Report 20212022 | Third Faculty of Medicine, First Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen
- Direct costs in patients with nonvalvular atrial fibrillation newly indicated to apixaban: a retrospective-prospective single-arm cohort study2022 | Third Faculty of Medicine, First Faculty of Medicine, Central Library of Charles University
- Real-life experience in the effectiveness, impact on quality of life and safety of dupilumab treatment in patients with moderate to severe atopic dermatitis in the Czech Republic2022 | Third Faculty of Medicine, First Faculty of Medicine, Central Library of Charles University
- Risankizumab for the Treatment of Moderate-to-Severe Psoriasis: Real-Life Multicenter Experience from the Czech Republic2021 | Third Faculty of Medicine, First Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen
Loading network view...